Anand Bhaskar

Number of records: 15
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
13-Sep-24 5:26 PM
View: 
Summit Therapeutics Inc. (SMMT) 11-Sep-24Grant 22,026$22.70$499,990.0020%
109.4K to 131.43K
26-Sep-23 4:30 PM
View: 
Reata Pharmaceuticals Inc (RETA) 26-Sep-23Disposition 24,089----(100%)
24.09K to 0
07-Sep-23 4:11 PM
View: 
Reata Pharmaceuticals Inc (RETA) 05-Sep-23Private Sale 406$169.20$68,695.20(2%)
24.5K to 24.09K
17-Aug-23 4:31 PM
View: 
Reata Pharmaceuticals Inc (RETA) 16-Aug-23Sale 210$168.42$35,367.90(< 1%)
24.7K to 24.5K
17-Aug-23 4:31 PM
View: 
Reata Pharmaceuticals Inc (RETA) 15-Aug-23Private Sale 193$169.05$32,627.60(< 1%)
24.9K to 24.7K
16-Jun-23 4:03 PM
View: 
Reata Pharmaceuticals Inc (RETA) 14-Jun-23Option Exercise 1,562$27.32$42,673.806%
25.68K to 27.24K
4%
16-Jun-23 4:03 PM
View: 
Reata Pharmaceuticals Inc (RETA) 14-Jun-23Private Option Sale 1,562$102.11$159,499.00(6%)
27.24K to 25.68K
16-Jun-23 4:03 PM
View: 
Reata Pharmaceuticals Inc (RETA) 14-Jun-23Sale 781$102.11$79,749.30(3%)
25.68K to 24.9K
17-May-23 4:26 PM
View: 
Reata Pharmaceuticals Inc (RETA) 16-May-23Sale 136$81.10$11,030.10(< 1%)
25.82K to 25.68K
17-May-23 4:26 PM
View: 
Reata Pharmaceuticals Inc (RETA) 15-May-23Private Sale 950$85.98$81,684.10(4%)
26.77K to 25.82K
08-Mar-23 5:08 PM
View: 
Reata Pharmaceuticals Inc (RETA) 07-Mar-23Private Sale 165$84.58$13,955.70(< 1%)
26.93K to 26.77K
06-Mar-23 4:31 PM
View: 
Reata Pharmaceuticals Inc (RETA) 03-Mar-23Private Sale 820$87.47$71,725.40(3%)
27.75K to 26.93K
02-Mar-23 5:15 PM
View: 
Reata Pharmaceuticals Inc (RETA) 01-Mar-23Grant 3,000----12%
24.75K to 27.75K
04-Jan-23 4:07 PM
View: 
Reata Pharmaceuticals Inc (RETA) 03-Jan-23Grant 8,250----50%
16.5K to 24.75K
05-Jan-22 4:10 PM
View: 
Reata Pharmaceuticals Inc (RETA) 03-Jan-22Grant 12,500----312%
4.0K to 16.5K